Back to first-pass browser

First-pass extracted concept

CRISPR-Cas live-cell imaging

Candidate: concept label1 source documents6 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

This approach uses nuclease-deactivated Cas proteins with programmable guide RNAs to track genomic loci in living cells. The abstract frames it as a central method for observing genome dynamics, nuclear organization, and chromatin behavior.

Source 1DOIPubMed

Resources required

The abstract explicitly states that the method couples dCas with programmable guide RNAs, and also discusses multicolor labeling, amplification systems, and fluorescent reporters as relevant components.

Source 1DOIPubMed

What problem it solves

It enables direct live-cell visualization of genomic loci with specificity and flexibility across the genome.

Source 1DOIPubMed

What it does not solve

The abstract states that non-repetitive loci remain difficult to label because of weak signal and high background, and that prolonged CRISPR expression can introduce toxicity and genome-stability liabilities.

Source 1DOIPubMed

Alternatives

The abstract does not name alternative non-CRISPR live-cell genome imaging platforms.

Source 1DOIPubMed

Evidence Snippets

CRISPR-Cas-based live-cell imaging has rapidly become a central technology for studying genome dynamics with high specificity and flexibility.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1capability improvementsupports2026Source 1DOIPubMed

Recent multicolor labeling, amplification, and fluorescent reporter advances have expanded the applicability of CRISPR imaging across the genome.

Quoted textsource-backed
Recent advances, including multicolor labeling strategies, innovative amplification systems based on dCas9 and single-guide RNA (sgRNA) engineering, and integration with novel fluorescent reporters, have markedly expanded the applicability of CRISPR imaging across the genome.
Claim 2mechanismsupports2026Source 1DOIPubMed

Coupling nuclease-deactivated Cas with programmable guide RNAs enables tracking of genomic loci in living cells.

Quoted textsource-backed
By coupling nuclease-deactivated Cas (dCas) with programmable guide RNAs, genomic loci can be tracked in living cells
Claim 3performance improvementsupports2026Source 1DOIPubMed

Recent CRISPR imaging developments have increased multiplexing capacity, improved signal-to-background ratios, and enabled visualization of non-repetitive genomic loci.

Quoted textsource-backed
These developments have expanded the multiplexing capacity of CRISPR imaging, improved signal-to-background ratios, and even enabled the visualization of non-repetitive genomic loci.
Claim 4performance limitationsupports2026Source 1DOIPubMed

Non-repetitive genomic loci are more difficult to label than repetitive regions because of weak signals and high background.

Quoted textsource-backed
While repetitive regions such as telomeres and centromeres are readily visualized, labeling non-repetitive loci remains more challenging due to weak signals and high background.
Claim 5safety limitationsupports2026Source 1DOIPubMed

Prolonged CRISPR expression in live-cell imaging is associated with cellular toxicity, replication stress, and genomic instability.

Quoted textsource-backed
Nonetheless, key challenges remain, including cellular toxicity, replication stress, and genomic instability associated with prolonged CRISPR expression.
Claim 6technology rolesupports2026Source 1DOIPubMed

CRISPR-Cas live-cell imaging is a central technology for studying genome dynamics with high specificity and flexibility.

Quoted textsource-backed
CRISPR-Cas-based live-cell imaging has rapidly become a central technology for studying genome dynamics with high specificity and flexibility.